Highlights: 1,108 fresh cases push Jharkhand’s Covid-19 tally to nearly 84,000
The Union home ministry on Wednesday issued guidelines for re-opening of economic activities in India amid the Covid-19 pandemic.
- 05:29 PM IST
Spain's debt soars as Covid-19 slams economy
- 04:59 PM IST
Covid-19 cases rising among American children as schools reopen
- 04:21 PM IST
North Korea on Covid-19 threat: 'Under safe and stable control'
- 03:44 PM IST
327 new cases take Maharashtra Police's tally to 23,360
- 02:29 PM IST
UK witnesses worst-ever spike, highest deaths since July
- 01:53 PM IST
491 new cases, 458 discharges and four deaths in Puducherry
- 01:44 PM IST
Himachal Pradesh's Covid-19 count rises to 14,750
- 01:14 PM IST
Odisha records 3,443 new Covid-19 cases; tally reaches 219,119
- 12:14 PM IST
Unlock 5 guidelines likely to be announced today
- 12:07 PM IST
Germany's CureVac says will test vaccine with 30,000 volunteers
- 10:55 AM IST
US firm says its Covid-19 treatment reduces viral levels and improves symptoms
- 10:11 AM IST
74,196,729 samples tested for Covid-19 till September 29: ICMR
- 09:19 AM IST
India records 80,472 new Covid-19 cases and 1,179 deaths in last 24 hours
- 09:10 AM IST
Chinese firm gets approval for clinical trial of vaccine candidate
- 08:32 AM IST
Donald Trump calls Covid-19 'China's fault'
After registering a dip in the daily cases logged on Tuesday, India's daily Covid-19 tally on Wednesday shot up again as 80,742 new cases and 1,179 related deaths were registered in the last 24 hours, according to the Union health ministry's dashboard. The country's tally has climbed to over 6.2 million which includes 940,441 active cases, nearly 5.2 million recoveries and 97,497 deaths.
The Union home ministry on Wednesday issued guidelines for re-opening of economic activities in the country amid the Covid-19 pandemic. Cinema halls, multiplexes will be allowed to open from October 15 while for re-opening of schools and coaching institutions, state/ UTs have been given the flexibility to take a decision after October 15.
Click here for full Covid-19 coverage
Meanwhile, Oxford University on Wednesday said that it would study whether the world’s best-selling prescription medicine, adalimumab, was an effective treatment for those infected with Covid-19 adding that 750 patients from community care settings across UK will be enrolled.
Catch all the major highlights here:
Spain's debt soars as Covid-19 slams economy
Spain's public debt soared in the second quarter to its highest level in at least two decades as government spending leapt in response to the Covid-19 pandemic, official figures showed Wednesday. "The government has decided to suspend budgetary rules in an extraordinary fashion for 2020 and 2021," finance minister Maria Jesus Montero told a news conference, reports AFP.
Covid-19 cases rising among American children as schools reopen
After preying heavily on the elderly in the spring, Covid-19 is increasingly infecting American children and teens in a trend authorities say appears fueled by school re-openings and the resumption of sports and other activities, reports AP.
North Korea on Covid-19 threat: 'Under safe and stable control'
North Korea on Tuesday called on global governments to “display effective leadership” in the fight against Covid-19 and said its own measures against the pandemic, which it called “preemptive, timely and strong,” ensured it had the threat “under safe and stable control," reports AP.
327 new cases take Maharashtra Police's tally to 23,360
327 new cases and one death in Maharashtra Police in last 24 hours. Total caseload reaches 23,360 including 20,139 recoveries, 2,975 active cases and 246 deaths.
UK witnesses worst-ever spike, highest deaths since July
The United Kingdom, which has the highest death toll in Europe, reported 7,143 new Covid-19 cases on Tuesday--its highest spike--as well 71 deaths, highest in a day since July.
491 new cases, 458 discharges and four deaths in Puducherry
Puducherry reports 491 new Covid-19 cases, 458 discharges, and four deaths taking the total number of positive cases to 27,544 so far, including 4,949 active cases, 22,074 recovered cases and 521 deaths: Health department
Himachal Pradesh's Covid-19 count rises to 14,750
Himachal Pradesh reports 3 new #COVID19 cases since 9 pm bulletin yesterday. Total positive cases in the state stand at 14,750, including 11,173 recoveries, 180 deaths and 3,372 active cases till date: State Health Department, Govt of Himachal Pradesh pic.twitter.com/9XPD6zFBE3
— ANI (@ANI) September 30, 2020
Odisha records 3,443 new Covid-19 cases; tally reaches 219,119
3,443 new Covid-19 cases, 3,869 recoveries and 14 deaths reported in Odisha. Tally rises to 219,119 including 181,481 recoveries, 36,743 active cases and 842 deaths: State health department
Unlock 5 guidelines likely to be announced today
The Centre is likely to announce guidelines for Unlock 5 later in the day. The fourth stage of unlock, which started on September 1, ends today.
Germany's CureVac says will test vaccine with 30,000 volunteers
German biopharmaceutical company CureVac has said it has started a mid-stage study testing of its its experimental coronavirus vaccine and plans to begin a decisive global trial with about 30,000 volunteers, Reuters has reported.
US firm says its Covid-19 treatment reduces viral levels and improves symptoms
US firm Regeneron Pharmaceuticals Inc has said its experimental two-antibody cocktail reduces viral levels and improved symptoms in non-hospitalized Covid-19 patients.
74,196,729 samples tested for Covid-19 till September 29: ICMR
A total of 7,41,96,729 samples tested for #COVID19, up to 29th September. Of these, 10,86,688 samples were tested yesterday: Indian Council of Medical Research (ICMR) pic.twitter.com/M9OGx2CUNj
— ANI (@ANI) September 30, 2020
India records 80,472 new Covid-19 cases and 1,179 deaths in last 24 hours
India records 80,472 new cases of Covid-19, 86,428 recoveries and 1,179 deaths. Tally reaches 6,225,763 including 5,187,825 recoveries, 940,441 active cases and 97,497 deaths.
Chinese firm gets approval for clinical trial of vaccine candidate
China’s Shenzhen Kangtai Biological Products has said it plans to launch a clinical trial of its coronavirus vaccine candidate as soon as possible after it had obtained regulatory approval from the Chinese medical products regulator.
First published: Sep 30, 2020 07:08 IST